T1	Drug 188 198	sertraline
A1	Person T1 3rd
A2	Duration T1 Regular
N1	Reference T1 Concepts:5203	Sertraline
T2	Disease_Symptom 151 149;160 164	 rash
A3	Person T2 3rd
N2	Reference T2 Concepts:0	Disagreement in Concept ID
#1	AnnotatorNotes T2	Disagreement in concept ID: C0234913 Vs. C0033774
T3	Disease_Symptom 137 135;160 164	 rash
A4	Person T3 3rd
N3	Reference T3 Concepts:0	Disagreement in Concept ID
#2	AnnotatorNotes T3	Disagreement in concept ID: C0234913 Vs. C0423791
T4	Disease_Symptom 137 149;160 164	erythematous rash
A5	Person T4 3rd
N4	Reference T4 Concepts:C0234913	Rash erythematous
T5	Disease_Symptom 151 159	pruritic
A6	Person T5 3rd
N5	Reference T5 Concepts:C0033774	Pruritus
T6	Disease_Symptom 80 94	panic disorder
A7	Person T6 3rd
N6	Reference T6 Concepts:C0030319	Panic Disorder
T7	Disease_Symptom 151 135;160 164	 rash
A8	Person T7 3rd
N7	Reference T7 Concepts:0	Disagreement in Concept ID
#3	AnnotatorNotes T7	Disagreement in concept ID: C0423791 Vs. C0033774
T8	Disease_Symptom 122 135;160 164	maculopapular rash
A9	Person T8 3rd
N8	Reference T8 Concepts:C0423791	Rash maculo-papular
T9	Disease_Symptom 137 135;160 164	 rash
A10	Person T9 3rd
N9	Reference T9 Concepts:0	Disagreement in Concept ID
#4	AnnotatorNotes T9	Disagreement in concept ID: C0423791 Vs. C0234913
T10	Drug 38 48	paroxetine
A11	Person T10 3rd
N10	Reference T10 Concepts:4691	Paroxetine
T11	Drug 53 63	sertraline
A12	Person T11 3rd
N11	Reference T11 Concepts:5203	Sertraline
R1	Outcome-negative Arg1:T1 Arg2:T9
R2	Outcome-negative Arg1:T1 Arg2:T9
R3	Outcome-negative Arg1:T1 Arg2:T9
R4	Outcome-negative Arg1:T1 Arg2:T4
R5	Outcome-negative Arg1:T1 Arg2:T4
R6	Outcome-negative Arg1:T1 Arg2:T4
R7	Benefit Arg1:T6 Arg2:T11
R8	Benefit Arg1:T6 Arg2:T10
R9	Outcome-negative Arg1:T1 Arg2:T5